儿童青少年健康伙伴关系儿科整合医疗模式对医疗服务使用和儿童健康结局的影响:一项实用性双臂整群随机对照试验
BACKGROUND: Paediatric health systems across high-income countries are facing avoidable adverse outcomes and increasing demands and costs.…
要点
- CYPHP组哮喘照护质量较EUC组显著提高,其他次要结局未见显著改善。
核心结论
- CYPHP整合医疗模式对主要结局非择期住院和儿科生活质量未显示效果,但在部分次要结局如湿疹症状和哮喘照护质量上有临床重要改善。
研究设计与样本
- CYPHP干预于2018年4月1日至2021年6月30日实施,分析纳入干预期间未满16岁且2021年6月30日注册于研究诊所的儿童。
- 主要结局为截至2021年6月30日全试验人群的非择期住院(NELA)和招募后6个月有示踪病症(哮喘、湿疹、便秘)参与者的儿科生活质量(PedsQL)。
主要发现
- CYPHP组哮喘照护质量较EUC组显著提高,其他所有次要结局未见显著改善。
关键数值与推荐
- CYPHP模型包含EUC全部要素(电子决策支持、初级保健热线、健康检查、自我管理支持与健康促进、韧性建设和心理健康急救)以及由儿科医生和全科医生提供的本地儿童健康诊所和护士主导的示踪病症(哮喘、湿疹、便秘)早期干预服务。
- EUC为增强常规照护,包含电子决策支持、初级保健热线、健康检查、自我管理支持与健康促进、韧性建设和心理健康急救。
临床怎么用
- 对于需要照护的湿疹和哮喘儿童,CYPHP整合医疗模式可考虑用于改善症状和照护质量。
- CYPHP模式未显示降低全人群非择期住院或改善儿科生活质量,实施时需结合本地资源与需求评估。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paediatric health systems across high-income countries are facing avoidable adverse outcomes and increasing demands and costs. The aim of this study was to compare the effect of an enhanced usual care model with that of an integrated health-care model that offers local health clinics for general paediatric problems and early intervention and care for children and young people with tracer conditions. METHODS: In this pragmatic two-arm cluster randomised controlled trial, we compared the Children and Young People's Health Partnership (CYPHP) model of care versus enhanced usual care (EUC) among children registered at general practices in south London, UK. The CYPHP trial intervention was delivered between April 1, 2018, and June 30, 2021, and children younger than 16 years during the intervention period and registered at study practices on June 30, 2021, were included in the analysis. A restricted randomisation (1:1) following a computer-generated sequence was done by a masked independent statistician at the level of general practice cluster, stratified by borough (Lambeth or Southwark). Cluster allocation and data collection were masked, with unmasking of trial statisticians before analysis. The CYPHP model comprised all elements of EUC (electronic decision support, a primary care hotline, health checks, self-management support and health promotion, and resilience building and mental health first aid) plus local child health clinics delivered by paediatricians and general practitioners, and a nurse-led early intervention service for children with tracer conditions (asthma, eczema, and constipation). Primary outcomes were non-elective admissions (NELA; admissions coded as an emergency) among the whole trial population up to June 30, 2021, and paediatric quality of life (Pediatric Quality of Life Inventory [PedsQL]) among participants with tracer conditions at 6 months after recruitment. Secondary outcomes were primary and secondary care use, child mental health, parental wellbeing, standardised symptom scores for asthma, eczema, and constipation, health-care quality, and child absences from school and parent absences from work. The trial was registered on ClinicalTrials.gov, NCT03461848, and is complete. FINDINGS: The trial was conducted between April 1, 2018, and Dec 31, 2021. In total, 23 general practice clusters, consisting of 70 practices with 97 970 registered children, were randomised to CYPHP (n=11) or EUC (n=12). We found no effect, at the population level, of CYPHP versus EUC on non-elective admissions during the intervention period (adjusted mean incidence rate ratio [IRR] 1·00 [95% CI 0·91 to 1·10], p=0·99). Among children with tracer conditions, we found no difference in paediatric quality of life (PedsQL score) at 6 months (adjusted mean difference -0·033 [95% CI -0·122 to 0·055], p=0·46). As a secondary outcome, among children with tracer conditions and requiring care, NELA rates at 12 months did not differ between the CYPHP and EUC groups (66·1 per 1000 person-years vs 75·3 per 1000 person-years; adjusted mean IRR 0·87 [0·61-1·22], p=0·42). In children requiring care, a statistically significant improvement was observed in eczema symptoms at 6 months from baseline in the CYPHP group versus the EUC group (adjusted mean difference -1·370 [-2·630 to -0·122], p=0·032). Quality of asthma care significantly improved among children in the CYPHP group compared with children in the EUC group. No significant improvement was seen for all other secondary outcomes. INTERPRETATION: Although the CYPHP trial found a null effect for the primary outcomes, we found clinically important improvements in some secondary outcomes including care quality. Previous research has shown that large-scale system change requires time to observe a potential positive effect. FUNDING: Guy's and St Thomas Charity, the Lambeth and Southwark Clinical Commissioning Groups, and Evelina London Children's Hospital.
引用
- Wolfe I, Forman J, Cecil E, et al. Effect of the Children and Young People's Health Partnership model of paediatric integrated care on health service use and child health outcomes: a pragmatic two-arm cluster randomised controlled trial. Lancet Child Adolesc Health. 2023. PMID: 37866369. doi:10.1016/S2352-4642(23)00216-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。